Qualità delle prove 4.75/5
Punteggio di revisione su otto dimensioni rispetto alla griglia di qualità . Ogni dimensione valutata da 1 a 5.
- D1 Ancoraggio alle fonti
- 4/5
- D2 Autorità delle fonti
- 5/5
- D3 Aritmetica
- 5/5
- D4 Incertezza
- 4/5
- D5 Ambito
- 5/5
- D6 Prosa
- 5/5
- D7 Onestà sulla percezione
- 5/5
- D8 Completezza degli avvertimenti
- 5/5
Come varia il rischio
La cifra principale è una media di situazioni molto diverse. Ecco come varia la probabilità in base allo scenario o al contesto:
—
At 200–400 mg aspartame/day, exposure is 7–14% of the ADI. No regulatory body identifies measurable cancer risk at this level.
—
At 800+ mg/day, still below half the ADI for a 70 kg adult. No cohort data shows dose-response at this range; Debras et al. grouped all above-median consumers together.
—
Saccharin was delisted as a carcinogen by the NTP in 2000 after the rat-bladder mechanism was shown to be species-specific. FDA, EFSA, and JECFA all consider saccharin safe at approved levels.
—
Sucralose has not been classified by IARC. FDA approved it in 1998; no large cohort study has linked it to cancer in humans at dietary exposure levels.
La lunghezza e la tonalità della barra ordinano questi scenari tra loro, non rispetto ad altri rischi. Le probabilità esatte sono indicate accanto a ciascuno.
Nel luglio 2023, l’IARC ha classificato l’aspartame come Gruppo 2B — “possibilmente cancerogeno per l’uomo” — e i titoli dei giornali si sono scritti da soli. Ciò che la maggior parte della copertura mediatica ha omesso: lo stesso giorno, il JECFA ha riaffermato l’attuale dose giornaliera accettabile di 40 mg/kg/giorno, non trovando alcuna ragione per modificarla. Un adulto di 70 kg dovrebbe consumare circa 14 lattine di bibita dietetica al giorno per raggiungere tale soglia. L’unica coorte che ha guidato la classificazione, Debras et al. 2022, ha riportato un hazard ratio di 1.13 per i consumatori al di sopra della mediana rispetto ai non consumatori — un effetto modesto il cui limite inferiore di confidenza esclude a malapena 1.0, proveniente da uno studio osservazionale con dati dietetici auto-riferiti e senza replicazione. FDA, EFSA e JECFA mantengono tutte che l’aspartame è sicuro ai livelli di consumo attuali.
Il modello è familiare. La saccarina fu bandita in Canada nel 1977 e quasi bandita negli Stati Uniti dopo che studi trovarono tumori alla vescica nei ratti. Due decenni dopo, il meccanismo si rivelò essere specie-specifico: i ratti maschi producono una proteina che si lega ai metaboliti della saccarina nell’urina e irrita l’epitelio della vescica. Gli esseri umani non producono questa proteina. L’NTP ha rimosso la saccarina dalla lista dei cancerogeni nel 2000. La categoria Gruppo 2B dell’IARC contiene oltre 300 agenti — inclusi l’estratto di foglie intere di aloe vera, le verdure sottaceto e l’esposizione professionale come pompiere — e segnala “prove limitate, da monitorare,” non “questo provoca il cancro alla dose sulla tua tavola della colazione.”
Nessun organismo di regolamentazione in nessuna parte del mondo ha quantificato una probabilità di cancro attribuibile al consumo di dolcificanti artificiali a livelli approvati. Il divario tra la percezione pubblica e il consenso normativo è netto: i consumatori evitano le bibite dietetiche per paura del cancro mentre tre agenzie indipendenti (FDA, EFSA, JECFA), esaminando le stesse prove, concludono che il rischio attribuibile non è distinguibile da zero a un’assunzione normale. Ciò non significa che la ricerca futura non possa cambiare il quadro — significa che le prove attuali non supportano un numero, e pubblicarne uno sarebbe una fabbricazione travestita da quantificazione.
Curiosità correlate
Non esiste una stima affidabile che colleghi i dolcificanti approvati al cancro a un consumo normale. Le revisioni normative e i grandi studi di coorte non hanno stabilito un effetto causale, quindi non pubblichiamo alcun numero invece di inventarne uno.
Registro delle fonti
Ogni numero qui sotto è ciò che ciascuna fonte ha riportato, con la citazione testuale su cui ci siamo basati e come siamo arrivati alla nostra cifra. Clicca su qualsiasi link per verificare direttamente.
1/6 fonti verificate in modo indipendente e alla lettera rispetto alla fonte citata
-
[1] International Agency for Research on Cancer (WHO) — Summary of Results — IARC Monographs Volume 134: Aspartame
Summary of Results — IARC Monographs Volume 134: Aspartame- Statistica
Aspartame classified as Group 2B (possibly carcinogenic to humans) based on limited evidence in humans and less than sufficient evidence in experimental animals- Estratto
“"The working group classified aspartame as possibly carcinogenic to humans (Group 2B) based on limited evidence for cancer in humans (for hepatocellular carcinoma," ”
- Dati originali da
- 2023-07-14
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- IARC's Group 2B is the third of four levels and indicates limited evidence in humans plus less than sufficient evidence in animals — it is a hazard-identification classification, not a risk quantification. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and radio-frequency electromagnetic fields. The classification does not estimate the probability of cancer at any exposure level, and IARC explicitly noted that the evidence came primarily from a single cohort (NutriNet-Santé) with effect sizes that were borderline after correction for multiple comparisons.
-
[2] World Health Organization / Joint FAO/WHO Expert Committee on Food Additives (JECFA) — Aspartame hazard and risk assessment results released Verificato
Aspartame hazard and risk assessment results released- Statistica
JECFA reaffirmed the existing ADI of 0–40 mg/kg body weight/day, finding no convincing evidence of harm at current consumption levels- Estratto
“"JECFA concluded that the data evaluated indicated no sufficient reason to change the previously established acceptable daily intake (ADI) of 0-40 mg/kg body weight for aspartame." ”
- Dati originali da
- 2023-07-14
- Consultato
- 2026-04-18 · copia archiviata
- Verifica
- Estratto recuperato in modo indipendente e confermato parola per parola rispetto alla fonte citata durante il nostro audit di attendibilità.
- Calcolo
- JECFA's evaluation was released simultaneously with IARC's classification. For a 70 kg adult, the ADI of 40 mg/kg/day equals 2,800 mg/day. A 355 ml (12 oz) can of diet soda contains roughly 200 mg of aspartame. Reaching the ADI would require consuming approximately 14 cans per day — a level well beyond typical consumption of 1–2 cans. JECFA and IARC used different frameworks: IARC identifies hazard (can it cause cancer under any conditions?), JECFA assesses risk (does it cause cancer at actual human exposure levels?). The divergence is methodological, not contradictory.
-
[3] PLoS Medicine / Debras et al. — Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study
Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study- Statistica
Higher consumers of artificial sweeteners (above median) had HR 1.13 (95% CI 1.03–1.25) for overall cancer risk vs non-consumers- Estratto
“"Compared to non-consumers, higher consumers of total artificial sweeteners (i.e., above the median exposure in consumers) had higher risk of overall cancer (n = 3,358 cases, hazard ratio [HR] = 1.13 [95% CI 1.03 to 1.25], P-trend = 0.002)." ”
- Dati originali da
- 2022-03-24
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- Debras et al. followed 102,865 adults from the French NutriNet-Santé cohort (2009–2021). The reported HR of 1.13 is modest and the lower confidence bound (1.03) barely excludes 1.0. The study is observational with self-reported dietary intake, subject to residual confounding (diet-soda consumers may differ systematically from non-consumers). This is the primary human study cited by IARC for the 2B classification. No prior large cohort has replicated the finding. The authors themselves note the result warrants replication and does not establish causation.
-
[4] U.S. Food and Drug Administration — Aspartame and Other Sweeteners in Food
Aspartame and Other Sweeteners in Food- Statistica
FDA does not agree with IARC's conclusion that aspartame is a possible carcinogen; FDA considers aspartame safe at current approved levels- Estratto
“"FDA disagrees with IARC’s conclusion that these studies support classifying aspartame as a possible carcinogen to humans. … FDA scientists do not have safety concerns when aspartame is used under the approved conditions." ”
- Dati originali da
- 2023-07-14
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- FDA's position reflects its own review of the same evidence considered by IARC, including the Ramazzini Institute animal studies (which FDA found methodologically flawed) and the NutriNet-Santé cohort. FDA has approved aspartame since 1981 and has reviewed its safety multiple times. The FDA ADI is 50 mg/kg/day — higher than JECFA's 40 mg/kg/day — reflecting an independent risk assessment reaching a similar conclusion of safety at normal consumption.
-
[5] European Food Safety Authority (EFSA) — Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive
Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive- Statistica
EFSA concluded aspartame and its breakdown products are safe for general population at current exposure levels, setting ADI at 40 mg/kg/day- Estratto
“"The Panel concluded that aspartame was not of safety concern at the current aspartame exposure estimates or at the ADI of 40 mg/kg bw/day." ”
- Dati originali da
- 2013-12-10
- Consultato
- 2026-04-18 · copia archiviata
- Calcolo
- EFSA's 2013 opinion was the most comprehensive regulatory review of aspartame to date, examining over 600 datasets. EFSA found no evidence of genotoxicity or carcinogenicity at doses below the ADI. Actual European population exposure was estimated at 2.8–10 mg/kg/day in high consumers — well below the ADI. This review predates the Debras et al. 2022 study but remains the benchmark regulatory assessment, and EFSA has not revised it following the IARC 2B classification.
-
[6] Wikipedia — Saccharin
Saccharin- Statistica
In 1977 the FDA attempted to completely ban saccharin after rat studies showed bladder tumors, but the ban was blocked by public opposition; Canada separately banned it as a food additive around the same time before later lifting that ban- Estratto
“"In 1977, the FDA made an attempt to completely ban the substance, following studies showing that the substance caused bladder cancer in rats. The attempted ban was unsuccessful due to public opposition that was encouraged by industry advertisements." ”
- Dati originali da
- 2026-06-01
- Consultato
- 2026-07-03 · copia archiviata
- Calcolo
- Supports the body's historical analogy between the 2023 IARC aspartame classification and the earlier saccharin cancer scare. Congress's Saccharin Study and Labeling Act of 1977 imposed an 18-month moratorium on the FDA's proposed ban and substituted a warning-label requirement instead; the FDA formally withdrew its 1977 ban proposal in 1991. Canada separately removed saccharin from sale as a food additive around 1977 and later lifted that restriction. Neither figure changes this entry's headline no_reliable_estimate status for sweeteners generally — this is background context for the saccharin-specific analogy in the body text, not a claim about artificial sweeteners currently on the market.